These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1382996)

  • 1. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.
    Lesley J; Hyman R
    Eur J Immunol; 1992 Oct; 22(10):2719-23. PubMed ID: 1382996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody.
    Lesley J; Kincade PW; Hyman R
    Eur J Immunol; 1993 Aug; 23(8):1902-9. PubMed ID: 7688309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
    Hathcock KS; Hirano H; Murakami S; Hodes RJ
    J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
    Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
    J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
    Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
    J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
    English NM; Lesley JF; Hyman R
    Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
    Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
    Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
    Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW
    J Exp Med; 1992 Jan; 175(1):257-66. PubMed ID: 1730918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
    Zahalka MA; Okon E; Gosslar U; Holzmann B; Naor D
    J Immunol; 1995 May; 154(10):5345-55. PubMed ID: 7537306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
    Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
    J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD44 cytoplasmic domain in hyaluronan binding.
    Perschl A; Lesley J; English N; Trowbridge I; Hyman R
    Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.
    Murakami S; Shimabukuro Y; Miki Y; Saho T; Hino E; Kasai D; Nozaki T; Kusumoto Y; Okada H
    J Immunol; 1994 Jan; 152(2):467-77. PubMed ID: 7506725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
    Gross N; Balmas K; Brognara CB
    Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion molecules on intermediate TCR cells. I. Unique expression of adhesion molecules, CD44+ L-selectin-, on intermediate TCR cells in the liver and the modulation of their adhesion by hyaluronic acid.
    Arai K; Iiai T; Nakayama M; Hasegawa K; Sato K; Ohtsuka K; Watanabe H; Hanyu T; Takahashi HE; Abo T
    Immunology; 1995 Jan; 84(1):64-71. PubMed ID: 7534265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
    Sleeman JP; Arming S; Moll JF; Hekele A; Rudy W; Sherman LS; Kreil G; Ponta H; Herrlich P
    Cancer Res; 1996 Jul; 56(13):3134-41. PubMed ID: 8674073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of homing receptors after T cell activation.
    Jung TM; Gallatin WM; Weissman IL; Dailey MO
    J Immunol; 1988 Dec; 141(12):4110-7. PubMed ID: 3058798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
    Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
    Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
    Wallach SB; Friedmann A; Naor D
    Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis.
    Mikecz K; Dennis K; Shi M; Kim JH
    Arthritis Rheum; 1999 Apr; 42(4):659-68. PubMed ID: 10211879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.